Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF‐kappa B.

Betsy Frantz; E.C. Nordby; Gary D. Bren; N M Steffan; C. V. Paya; Randall L. Kincaid; Michael J. Tocci; Stephen J. O’Keefe; Edward A. O’Neill

doi:10.1002/j.1460-2075.1994.tb06329.x

Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF‐kappa B.

Betsy Frantz(Merck & Co., Inc., Rahway, NJ, USA (United States)), E.C. Nordby(Merck & Co., Inc., Rahway, NJ, USA (United States)), Gary D. Bren(Merck & Co., Inc., Rahway, NJ, USA (United States)), N M Steffan(Merck & Co., Inc., Rahway, NJ, USA (United States)), C. V. Paya(Merck & Co., Inc., Rahway, NJ, USA (United States)), Randall L. Kincaid(Merck & Co., Inc., Rahway, NJ, USA (United States)), Michael J. Tocci(Merck & Co., Inc., Rahway, NJ, USA (United States)), Stephen J. O’Keefe(Merck & Co., Inc., Rahway, NJ, USA (United States)), Edward A. O’Neill(Merck & Co., Inc., Rahway, NJ, USA (United States))

The EMBO Journal

February 1, 1994

10.1002/j.1460-2075.1994.tb06329.x

Cited by 332Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis